Ronald Reagan UCLA Medical Center Drug Information Center is a clinical research site located in Los Angeles, California, United States 90095.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Ronald Reagan UCLA Medical Center Drug Information Center has participated in 14 clinical trials with 2 currently active.
Therapeutic areas: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Los Angeles
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ronald Reagan UCLA Medical Center Drug Information Center has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ronald Reagan UCLA Medical Center Drug Information Center has 14 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.
Ronald Reagan UCLA Medical Center Drug Information Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.